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Abstract
The role of spinal a2-adrenoceptors in mediating long-lasting modulation of hind limb withdrawal reflexes following acute noxious
chemical stimulation of distant heterotopic and local homotopic locations has been investigated in pentobarbitone-anaesthetized
rabbits. Reflexes evoked in the ankle extensor muscle medial gastrocnemius (MG) by electrical stimulation of the ipsilateral heel,
and reflexes elicited in the ankle flexor tibialis anterior and the knee flexor semitendinosus by stimulation at the base of the ipsilat-
eral toes, could be inhibited for over 1 h after mustard oil (20%) was applied to either the snout or into the contralateral MG. The
heel–MG response was also inhibited after applying mustard oil across the plantar metatarsophalangeal joints of the ipsilateral foot,
whereas this homotopic stimulus facilitated both flexor responses. Mustard oil also caused a significant pressor effect when applied
to any of the three test sites. The selective a2-adrenoceptor antagonist, RX 821002 (100–300 lg, intrathecally), had no effect on
reflexes per se, but did cause a decrease in mean arterial blood pressure. In the presence of the a2-blocker, inhibitory and facilita-
tory effects of mustard oil on reflexes were completely abolished. These data imply that long-lasting inhibition of spinal reflexes fol-
lowing acute noxious stimulation of distant locations involves activation of supraspinal noradrenergic pathways, the effects of which
are dependent on an intact a2-adrenoceptor system at the spinal level. These pathways and receptors also appear to be involved
in facilitation (sensitization) as well as inhibition of reflexes following a noxious stimulus applied to the same limb.
Introduction
In pentobarbitone-anaesthetized or decerebrated rabbits, withdrawal
reﬂexes of the hind limb are profoundly inhibited by noxious stimu-
lation of certain off-limb (heterotopic) sites, a ﬁnding comparable to
counter-stimulation phenomena such as diffuse noxious inhibitory
controls (DNIC; Le Bars et al., 1979a,b; Schouenborg & Dickenson,
1985; Villanueva & Le Bars, 1995; Le Bars & Willer, 2002), which
more recently has been termed ‘conditioned pain modulation’
(CPM) in humans (Yarnitsky et al., 2010). Thus, reﬂex responses in
the ankle extensor medial gastrocnemius (MG) evoked by electrical
stimulation of heel afferents, and responses in the ankle ﬂexor tib-
ialis anterior (TA) and the knee ﬂexor semitendinosus (ST) to stimu-
lation of the toes, could be depressed for over 1 h after the chemical
irritant mustard oil was applied either to the snout or into the MG
muscle of the contralateral hind limb (Harris & Clarke, 2003). In
the same studies, administration of mustard oil to off-limb sites in
decerebrated, spinalized animals had no modulatory effect on
reﬂexes, indicating that activation of one or more descending path-
ways is necessary for this inhibition to occur.
Anatomical tracing studies in the rabbit and other species have
shown that a major portion of the bulbospinal innervation of the
spinal cord is by ﬁbres containing the monoamines noradrenaline or
5-hydroxytryptamine (5-HT; Blessing et al., 1978, 1981; Howe
et al., 1983), descending pathways that are well established in medi-
ating inhibitory (and facilitatory) modulation of spinal nociceptive
activity (Millan, 2002; Ossipov et al., 2010), making either of these
neurotransmitters strong candidates for mediating the spinal effects
of mustard oil applied to off-limb sites. In this respect, studies in
the rat using single dorsal horn neurons or pain behaviour have indi-
cated the involvement of descending 5-HT-ergic pathways in DNIC
(Dickenson et al., 1981; Chitour et al., 1982; Kraus et al., 1982),
whilst the possible contribution of noradrenergic pathways has also
been suggested by studying dorsal horn neurons or tail ﬂick
responses (Gjerstad et al., 2000; Wen et al., 2010). The nature of
the descending pathways involved in heterotopic inhibition of speci-
ﬁc limb ﬂexor and extensor withdrawal reﬂexes has received little
attention, however, given the potential for reﬂex responses to be dif-
ferentially modulated by these pathways (Harris & Clarke, 2003).
Because it has previously been shown that inhibition of the heel–
MG reﬂex by high-intensity electrical stimulation of nerves in the
forelimbs and hind limbs is reduced by intravenous administration
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of the a2-adrenoceptor antagonist idazoxan (Taylor et al., 1991), the
present studies have therefore focused on the spinal role of nora-
drenergic pathways in mediating the effects of remotely applied
mustard oil by intrathecally applying a derivative of idazoxan, RX
821002 [2-methoxy-idazoxan; 2-(2,3-dihydro-2-methoxy-1,4-benzo-
dioxin-2-yl)-4,5-dihydro-1H-imidazole hydrochloride]. Like its par-
ent compound, RX 821002 is a selective a2-adrenoceptor antagonist
(Stillings et al., 1985; Welbourn et al., 1986) but, in contrast to ida-
zoxan, it does not possess any appreciable afﬁnity for non-adrener-
gic imidazoline receptors (Hudson et al., 1992; Clarke & Harris,
2002).
As well as off-limb sites, long-lasting modulation of hind limb
reﬂexes by mustard oil can also be induced from the same limb, but
the effect observed is highly dependent upon the part of the limb
stimulated and the reﬂex studied (Harris & Clarke, 2003). For
instance, mustard oil application to the plantar metatarsophalangeal
(MT) joints leads to inhibition of heel–MG reﬂex responses but,
contrary to this, ﬂexor responses are subject to prolonged facilita-
tion. This facilitation of ﬂexor responses is restricted to just the
plantar surface of the foot in intact animals, whereas facilitation can
be produced from all over the hind limb in spinalized animals, indi-
cating a role for tonic inhibitory pathways in spatially restricting
reﬂex sensitization so that only functionally protective withdrawal
responses are enhanced (Harris & Clarke, 2003). There is a wealth
of evidence to indicate that descending noradrenergic pathways inhi-
bit nociceptive transmission in the spinal cord via a2-adrenoceptors
(Millan, 2002; Pertovaara, 2006), and that a reduction in this inhibi-
tion contributes to hypersensitivity seen in the injured limb in mod-
els of acute inﬂammation (Green et al., 1998; Omote et al., 1998;
Mansikka et al., 2004) and nerve injury (Xu et al., 1999; Wei &
Pertovaara, 2006; Rahman et al., 2008; De Felice et al., 2011;
Hughes et al., 2013); however, again little is known about how
these pathways may be altered to inﬂuence cutaneo-muscular
reﬂexes in individual ﬂexor and extensor muscles. Therefore, the
effects of spinal administration of RX 821002 on mustard oil-
induced modulation of hind limb reﬂexes following its application
to the plantar MT joints (i.e. a homotopic site) have also been inves-
tigated in the same preparation in the present studies.
Materials and methods
General preparation
Experiments were performed on 19 rabbits of mixed strain and
either sex, weighing between 1.8 and 3.5 kg, in accordance with
the EC Directive 86/609/EEC for animal experiments, UK Animals
(Scientiﬁc Procedures) Act of 1986, and following approval by the
University of Nottingham ethical committee. Animals were sedated
with 50 mg i.m. ketamine sulphate (Fort Dodge Animal Health,
Southampton, UK) before pentobarbitone sodium (mean dose
45 mg/kg over 20 min, range 35–55 mg/kg) was administered via
a marginal ear vein to induce anaesthesia. The pentobarbitone
sodium solution (30 mg/mL in Ringer’s) was diluted from a stock
solution (60 mg/mL) prepared by dissolving powdered sodium pen-
tobarbital (6% w/v) in 20% v/v propylene glycol, 10.4% v/v etha-
nol (96%) and distilled water (all constituents from Sigma-Aldrich,
UK). All areas subject to surgery were pre-treated with 2% ligno-
caine solution s.c. or i.m. (about 100 lL per injection; Lignavet,
C-Vet Veterinary Products, Leyland, UK), and following surgery
lignocaine ointment (5%; Biorex Laboratories, Enﬁeld, UK) was
applied to any cut muscle and skin surfaces. The trachea was can-
nulated, then the left carotid artery and left jugular vein were also
cannulated to allow the measurement of arterial blood pressure and
administration of intravenous drugs, respectively. Anaesthesia was
maintained using a continuous i.v. infusion (at a mean rate of
17 mg/kg/h, range 13–24 mg/kg/h) of pentobarbitone sodium
(diluted from stock solution to 6 mg/mL using 100 mM D-glucose,
100 mM NaHCO3 solution; Sigma-Aldrich, UK). From this point,
animals were artiﬁcially ventilated on room air supplemented with
oxygen using a Harvard small animal ventilator with the stroke
volume set to maintain end tidal CO2 between 3.5 and 4.5%. To
allow direct spinal (intrathecal) application of drugs to the lum-
bosacral spinal cord, a ﬁne polyethylene cannula (o.d. = 0.63 mm;
Portex, Smiths Medical, Ashford, UK) was threaded caudally
beneath the dura mater via a laminectomy at the thoracolumbar
junction. No other invasive surgery was performed. The core tem-
perature of the animal was measured using a rectal probe and
maintained at 38  0.5 °C by a thermostatically controlled heating
blanket. An electrocardiogram was recorded using an intra-oesopha-
geal probe, and this triggered an instantaneous rate meter to pro-
vide a measurement of heart rate. The output from this rate meter,
as well as the ampliﬁed signal from a pressure transducer con-
nected to the cannula in the carotid artery, were continuously
recorded on a computer linked to a Cambridge Electronic Design
(CED, Cambridge, UK) micro1401 interface and running Spike2
for Windows v.3.
Stimulation and recording of reflexes
To evoke reﬂexes, paired stainless-steel needle electrodes were
inserted into the skin of the plantar surface of the left foot at the
heel and at the base of the toes. Blocks of eight constant-current
stimuli at 1 Hz and of 1 ms duration were then applied from AMPI
Isoﬂex stimulators alternately to the heel and toe electrodes at 2 min
intervals. In most cases, stimulus strength was set at 1–5 times the
threshold value for evoking reﬂex responses; however, in two exper-
iments (in one case for the heel–MG response and the other for
toes–ST or toes–TA responses) it was not possible to evoke measur-
able reﬂexes using eight single shocks at a stimulus strength up to
10 mA. Therefore, in these two instances, eight triple shocks (at
250 Hz) were given every second at strengths of 4.1 mA and
10 mA to evoke heel–MG responses and toes–ST or toes–TA
responses, respectively. The stimulus strength in each experiment
was based on obtaining reﬂex responses that had the capacity to
measurably increase or decrease in size following the conditioning
stimuli (Harris & Clarke, 2003; Harris et al., 2004). To this end, a
small increase in stimulation intensity was occasionally necessary
during a control period between conditioning stimuli (i.e. after at
least 1 h of post-conditioning responses had been measured and
reﬂexes had stabilized; see below).
Reﬂex responses to heel stimulation were recorded as compound
electromyogram signals from the ipsilateral MG extensor muscle
using paired, percutaneous, varnish-insulated copper wire electrodes.
Reﬂexes to toe stimulation were recorded in the same way from
ipsilateral TA and ST ﬂexor muscles. Signals were ampliﬁed (2000–
5000 times) and ﬁltered (between 1 Hz and 6 kHz), then digitized
using a CED 1401 interface before the full-wave rectiﬁed responses
to each block of eight stimuli were averaged and integrated by com-
puter using Signal v.2.12. As the duration of reﬂexes can vary
slightly between experiments, the analysis window was determined
for an individual experiment rather than ﬁxed for all experiments.
Measurement (voltage/time area) of short-latency heel–MG
responses was therefore performed between 9–12 ms (latency of
response) and 14–27 ms (return of response to baseline, i.e.
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duration), whilst the corresponding analysis window for toes–ﬂexor
responses was from 9–13 ms to 23–42 ms (Fig. 1).
Experimental protocol
Control reﬂex responses to heel and toe stimulation were recorded
for at least 30 min before the ﬁrst noxious conditioning stimulus
was applied. This consisted of 100 lL 20% mustard oil (allylisoth-
iocyanate; Sigma-Aldrich, UK) in parafﬁn oil, which was applied to
one of three sites: onto the skin of the plantar surface of the ipsilat-
eral foot across the MT joints; onto the skin of the snout; or it was
injected into the contralateral MG muscle. Heel–MG and toes–ﬂexor
reﬂexes were then measured for at least 1 h before mustard oil was
applied to one of the two previously unstimulated areas and the
recording period repeated. An identical procedure was followed after
the ﬁnal site received the noxious conditioning stimulus. The order
in which mustard oil was applied to the three sites was randomized
for each experiment. Subsequent to the ﬁrst round of mustard oil
stimuli, 10 animals (hereafter referred to as the RX 821002 treat-
ment group) were given the selective a2-adrenoceptor antagonist,
RX 821002 (Tocris, Bristol, UK) dissolved in Ringer’s solution,
intrathecally at a dose of 200 lg (seven animals) or 300 lg (three
animals) from stock solutions of 2 mg/mL and 3 mg/mL, respec-
tively (ﬂushed in with 50 lL Ringer’s), whilst nine animals received
no drug treatment (hereafter referred to as the control (no drug)
group). Previous studies have shown that intrathecal Ringer’s has no
effect on reﬂexes per se (Harris & Clarke, 1992; Clarke et al.,
2001a). The relatively high initial intrathecal dose of RX 821002
was chosen to ensure an effective local concentration of antagonist
was achieved at a2-adrenoceptors in the spinal cord following per-
meation into the grey matter. Reﬂexes were then recorded for
between 24 and 44 min until responses had become stable, then a
second round of mustard oil stimuli and reﬂex recording was initi-
ated. For each of the three stimulus sites, the second application of
mustard oil was given adjacent to, but not directly on top of, the site
of the ﬁrst mustard oil treatment. Very few data have been pub-
lished on the pharmacokinetics of RX 821002 (Clarke & Harris,
2002), and no deﬁnitive measurements have been made of duration
of action, but previous use has shown that it has effects that last
longer than 1 h in the rabbit. Therefore, in the group of animals
receiving RX 821002, booster doses at half the initial concentration
(i.e. 100 or 150 lg, intrathecally) were administered before mustard
oil was applied to the second and third sites. Experiments were ter-
minated by giving an overdose of anaesthetic followed by 2 mL of
saturated KCl solution.
Data handling and statistical analysis
The effect of mustard oil on reﬂex responses was determined by
expressing post-mustard oil readings as a percentage of the mean of
the three responses recorded immediately prior to the conditioning
stimulus. For each conditioning stimulus, the time taken for reﬂex
responses to recover (to within 2 standard deviations of the mean
pre-mustard oil control values for two consecutive readings) was
Fig. 1. Example electromyogram recordings and analysis time windows of reﬂex responses in (A) medial gastrocnemius (MG) and (B) semitendinosus
(ST)/tibialis anterior (TA) to electrical stimulation of the heel and toes, respectively. Each record is the average of eight sweeps and the stimulus was applied at
the beginning of each sweep. Placement of cursors for measurement of the voltage/time integral (area) of the response is indicated by the dashed lines.
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also determined, with cut-off values of 61 min for the heel–MG
reﬂex and 63 min for the ﬂexor reﬂexes. Because reﬂex responses
are generally not normally distributed, values within treatment
groups are expressed as medians with inter-quartile ranges (IQRs),
and the data have been analysed with non-parametric statistical tests
using GraphPad Prism v.5.02 (Graph Pad, San Diego, CA, USA).
Blood pressure and heart rate data were obtained from the Spike2
records by measuring average values over 1-min time bins. Because
arterial blood pressure and heart rate data were normally distributed,
standard parametric tests were used to assess statistical signiﬁcance.
A signiﬁcance level of 0.05 was assumed throughout.
Results
Stimulus intensities for evoking reflexes
The median threshold stimulus intensities required in control (no
drug) and RX 821002 treatment groups to evoke reﬂex responses in
MG from the heel, and in ST and TA from the toes, were not signif-
icantly different (Mann–Whitney tests, P > 0.05), so these data have
been pooled. Therefore, for all animals (i.e. n = 19), heel–MG
responses were evoked at a median threshold stimulus intensity of
3 mA (range 0.6–10 mA), and the corresponding value for toes–
ﬂexor responses was 1.5 mA (range 0.5–10 mA). Note that in both
cases, the upper range limit of 10 mA was the result of assigning
this threshold value to experiments where reﬂexes could not be
evoked using single shocks (see Materials and methods). Statistical
comparison of these data conﬁrmed previous ﬁndings in pentobarbi-
tone-anaesthetized rabbits, that the threshold for evoking reﬂexes in
MG from the heel was signiﬁcantly greater (Wilcoxon test,
P < 0.05) than that for evoking responses in TA and ST from the
toes, and may be due to a greater reduction in descending inhibitory
control of ﬂexor compared with extensor reﬂexes in this preparation
(Harris & Clarke, 2003).
The effects of intrathecal administration of the a2-adrenoceptor
antagonist RX 821002 per se
There were no obvious differences in the effects of the 200 lg and
300 lg intrathecal doses of RX 821002, so these data have been
pooled (i.e. n = 10). RX 821002 per se had no consistent or signiﬁ-
cant effect on any of the reﬂexes studied [Friedman’s ANOVA,
F = 4.714 (MG), 4.671 (TA), 6.729 (ST); P > 0.3 in each case];
however, it did have a signiﬁcant effect on cardiovascular parame-
ters [repeated-measures ANOVA, F20,180 = 6.5 (BP), F20,180 = 11
(HR); P < 0.0001 for both; Fig. 2]. Three minutes after RX 821002
administration, mean arterial blood pressure decreased by an average
of 18  4 mmHg from a pre-drug level of 90  4 mmHg, whereas
heart rate subsequently increased by 12  3 beats/min from a pre-
RX 821002 level of 300  9 bpm. Blood pressure and heart rate
returned to within control levels after a mean of 17  3 min and
22  2 min, respectively.
The effect on reflex responses of mustard oil injected into the
contralateral MG muscle
When injected for the ﬁrst time, mustard oil into the contralateral
MG signiﬁcantly inhibited all three reﬂexes in both treatment groups
[Friedman’s ANOVA, RX 821002 treatment group: F = 25.33 (MG),
41.84 (TA), 26.40 (ST); control (no drug) group: F = 16.00 (MG),
17.72 (TA), 16.09 (ST); P < 0.05 in all cases]. Although a decrease
in responses was apparent immediately after injection of the mustard
oil, in all cases the full effect of this noxious stimulus did not
develop until at least 10 min later (Fig. 3), therefore values quoted
for the heel–MG response were taken 13 min after mustard oil was
applied and those for toes–ﬂexor reﬂexes were taken 15 min after-
wards. In the control (no drug) group, the ﬁrst conditioning stimulus
decreased responses in the heel–MG, toes–TA and toes–ST reﬂex
pathways to a median of 77% (IQR 43–82%), 70% (IQR 46–76%)
and 73% (IQR 43–78%) of pre-mustard oil levels, respectively, and
these decreases lasted for 47 min (IQR 28–61 min), at least 63 min
(IQR 63–63 min) and at least 63 min (IQR 27–63 min), respec-
tively. The corresponding values in the group to be given RX
821002 were 65% (IQR 52–80%), 43% (IQR 33–53%) and 60%
(IQR 52–80%) of controls for at least 61 min (IQR 34–61 min), at
least 63 min (IQR 63–63 min) and at least 63 min (IQR 7–63 min;
Fig. 3). For all three reﬂex responses, these effects of mustard oil
were not signiﬁcantly different between the two treatment groups
(Mann–Whitney tests, P > 0.1).
Following administration of RX 821002 (100–300 lg, intrathe-
cally), a mustard oil injection into the contralateral MG had no
signiﬁcant (Friedman’s ANOVA, F = 9.413; P > 0.3) effect on the
heel–MG reﬂex, which tended to increase above pre-injection levels
rather than being subject to inhibition (Fig. 3). Similarly, mustard
oil failed to induce any signiﬁcant [Friedman’s ANOVA, F = 12.43
(TA), 5.813 (ST); P > 0.1 in each case] inhibition of either
ﬂexor reﬂex in the presence of RX 821002. However, when the
Fig. 2. Effect of the selective a2-adrenoceptor antagonist RX 821002 on
reﬂex responses (top panel) and cardiovascular parameters (bottom panel)
(n = 10). For reﬂexes, column height represents the median response and
error bars are 1st quartile values. For cardiovascular data, points are means
and error bars are SEM. RX 821002 was given intrathecally (200–300 lg) at
time 0.
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contralateral MG muscle received a repeat mustard oil injection in
the control (no drug) group, heel–MG responses were signiﬁcantly
(Friedman’s ANOVA, F = 24.15; P < 0.01) inhibited a second time to
a median of 79% (IQR 32–98%) of pre-mustard levels, as were TA
and ST responses to toe stimulation [Friedman’s ANOVA, F = 29.63
(TA), 19.02 (ST); P < 0.05 in each case], which declined to a med-
ian of 56% (IQR 45–77%) and 59% (IQR 45–85%) of controls. The
median duration of these decreases was for at least 61 min (IQR
45–61 min), at least 63 min (IQR 51–63 min) and at least 63 min
(IQR 27–63 min) for the heel–MG, toes–TA and toes–ST responses,
respectively. For all reﬂexes, these effects were not signiﬁcantly
different to those achieved with the ﬁrst mustard oil stimulus
(Wilcoxon tests, P > 0.3).
The effect on reflex responses of mustard oil applied to the
snout
Application of the ﬁrst mustard oil stimulus to the snout resulted in
a signiﬁcant inhibition of all three reﬂexes responses [Friedman’s
ANOVA, RX 821002 treatment group: F = 21.99 (MG), 29.30 (TA),
17.48 (ST); control (no drug) group: F = 17.54 (MG), 42.34 (TA),
27.08 (ST); P < 0.05 in all cases] that took 7–11 min to fully
develop, so again quoted values for extensor and ﬂexor reﬂex
responses have been taken 13 min and 15 min after mustard oil,
respectively. For the heel–MG reﬂex, a conditioning stimulus to the
snout caused a decrease in responses to a median of 82% (IQR 31–
102%) and 78% (IQR 60–123%) of pre-mustard oil levels in control
(no drug) animals and in the group to be given RX 821002, respec-
tively (Fig. 4). The median duration of this inhibition was 17 min
(IQR 0–33 min) for the control (no drug) group and 17 min (IQR
3–39 min) for the RX 821002 treatment group. The extent and dura-
tion of these inhibitions were not signiﬁcantly different between the
two groups (Mann–Whitney tests, P > 0.6). For the ﬂexor reﬂexes,
mustard oil to the snout inhibited the toes–TA and toes–ST
responses to a median of 58% (IQR 56–66%) and 59% (IQR
39–79%) of pre-mustard levels in the control (no drug) group, and
this depression lasted for a median duration of at least 63 min (IQR
43–63 min) and 39 min (35–63 min), respectively. The correspond-
ing values for animals that were going to receive RX 821002 were
inhibition to 52% (IQR 43–72%) and 84% (IQR 64–86%) of
controls for a duration of 63 min (IQR 35–63 min) and at least
35 min (IQR 23–63 min). Again, these values did not differ
between the two treatment groups (Mann–Whitney tests, P > 0.2).
The inhibitory effect on the heel–MG reﬂex of mustard oil
applied to the snout was completely abolished by pre-administration
of RX 821002, and in fact a small but signiﬁcant (Friedman’s
ANOVA, F = 19.56; P < 0.05) increase in the MG response was seen
to a median of 117% (IQR 106–159%) of pre-mustard controls
(Fig. 4). This increase lasted for a median of 29 min (IQR
0–41 min). The presence of RX 821002 also led to mustard oil hav-
ing no signiﬁcant effect [Friedman’s ANOVA, F = 5.067 (TA), 5.719
(ST); P > 0.6 for both] on the response of TA or ST to toe stimula-
tion (Fig. 4). However, in control (no drug) animals, application of
mustard oil to the snout for a second time caused a signiﬁcant
[Friedman’s ANOVA, F = 33.30 (TA), 19.47 (ST); P < 0.05 for both]
decrease in the toes–TA and toes–ST responses to a median of 68%
(IQR 47–81%) and 65% (IQR 55–83%) of pre-mustard levels for at
least 63 min (IQR 63–63 min) and 43 min (IQR 31–59 min),
Fig. 3. Effect of repeated mustard oil application to the contralateral medial gastrocnemius (MG) muscle ( ﬁrst injection;  second injection) on heel–MG,
toes–tibialis anterior (TA) and toes–semitendinosus (ST) reﬂexes in the absence (top panels) or presence (bottom panels) of RX 821002 (100–300 lg, intrathe-
cally) prior to the second injection. Each point on the graphs represents the median of nine (no drug group) or 10 (RX 821002 group) experiments, and the ver-
tical lines are either 1st or 3rd quartiles. Mustard oil was applied at 0 min. *Indicates a signiﬁcant difference in the effect of mustard oil at equivalent time
points before and after intrathecal RX 821002 (Wilcoxon tests, P < 0.05).
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respectively. These changes were not statistically distinguishable
from those achieved with the ﬁrst mustard oil stimulus (Wilcoxon
tests, P > 0.4).
The effect on reflex responses of mustard oil applied to the
plantar MT joints
In contrast to its application to off-limb sites, the peak changes fol-
lowing mustard oil to the ipsilateral plantar MT joints occurred
almost immediately post-stimulus, therefore for this site values for
the heel–MG reﬂex and the toes–ﬂexor responses have been taken
1 min and 3 min after mustard oil treatment, respectively. In both
control (no drug) and RX 821002 treatment groups, application of
the ﬁrst mustard oil stimulus to the MT joints caused the heel–MG
reﬂex to signiﬁcantly [Friedman’s ANOVA, F = 37.73 (RX 821002
treatment group), 37.03 (control (no drug) group); P < 0.0001 in
each case] decrease to a median of 30% (IQR 15–49%) and 35%
(IQR 24–47%) of pre-mustard oil levels, respectively (Fig. 5). For
control (no drug) animals, the median duration of this decrease was
33 min (IQR 21–53 min), whilst for those animals that were going
to receive RX 821002 this time was 35 min (IQR 13–51 min). The
size and duration of the mustard oil-induced inhibition were not sig-
niﬁcantly different between groups (Mann–Whitney tests, P > 0.5).
In contrast to the extensor response, the ﬁrst mustard oil application
to the MT joints signiﬁcantly [Friedman’s ANOVA, RX 821002 treat-
ment group: F = 39.31 (TA), 62.99 (ST); control (no drug) group:
F = 37.03 (TA), 24.36 (ST); P < 0.005 in each case] facilitated the
ﬂexor reﬂexes for both treatment groups. In the control (no drug)
group, increases were to a median of 187% (IQR 140–249%) and
675% (IQR 124–923%) of pre-mustard oil levels for the toes–TA
and toes–ST reﬂexes, respectively. In both cases, the median dura-
tion of these increases was at least 63 min (TA IQR 59–63 min; ST
IQR 15–63 min). In the group to receive intrathecal RX 821002, the
ﬁrst mustard oil application caused the toes–TA response to be
potentiated to a median of 336% (IQR 172–490%) of pre-stimulus
levels for at least 63 min (IQR 54–63 min), whilst the correspond-
ing values for the toes–ST reﬂex were 571% (IQR 254–921%) of
controls for a period of 57 min (IQR 51–63 min). The effects of this
ﬁrst mustard oil stimulus on each of the ﬂexor reﬂexes did not differ
between the two treatment groups (Mann–Whitney tests, P > 0.2).
When mustard oil was applied in the presence of RX 821002, an
inhibitory effect on the heel–MG reﬂex was no longer observed,
and instead a small but signiﬁcant (Friedman’s ANOVA, F = 17.87;
P < 0.005) increase in the MG response gradually occurred over
time (Fig. 5). By contrast, a second mustard oil application to the
MT joints in the control (no drug) group caused a signiﬁcant (Fried-
man’s ANOVA, F = 18.01; P < 0.05) inhibition of heel–MG
responses to a median of 34% (IQR 27–83%) of pre-stimulus levels
for 29 min (IQR 9–53 min), an effect that was not signiﬁcantly dif-
ferent to the ﬁrst mustard oil application to this site (Wilcoxon tests,
P > 0.2). The presence of RX 821002 also abolished [Friedman’s
ANOVA, F = 10.37 (TA), 6.320 (ST); P > 0.2 in both cases] the
facilitatory effect of mustard oil on both of the ﬂexor reﬂexes
(Fig. 5).
However, when the second mustard oil stimulus was applied to
the plantar MT joints in the control (no drug) treatment group, sig-
niﬁcant increases [Friedman’s ANOVA, F = 19.85 (TA), 28.44 (ST);
P < 0.05 in both cases] in the toes–TA reﬂex, to a median of 161%
Fig. 4. Effect of repeated mustard oil application to the snout ( ﬁrst application;  second application) on heel–medial gastrocnemius (MG), toes–tibialis ante-
rior (TA) and toes–semitendinosus (ST) reﬂexes in the absence (top panels) or presence (bottom panels) of RX 821002 (100–300 lg, intrathecally) prior to the
second injection. Each point on the graphs represents the median of nine (no drug group) or 10 (RX 821002 group) experiments, and the vertical lines are either
1st or 3rd quartiles. Mustard oil was applied at 0 min. *Indicates a signiﬁcant difference in the effect of mustard oil at equivalent time points before and after
intrathecal RX 821002 (Wilcoxon tests, P < 0.05).
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(IQR 112–197%) of pre-mustard oil levels, and the toes–ST
response, to a median of 198% (IQR 108–303%) of pre-mustard
controls, were still observed. Both reﬂexes were enhanced for a
median duration of at least 63 min (TA IQR 39–63 min; ST IQR
47–63 min). Comparison of the effects of the ﬁrst and second mus-
tard oil stimuli in this control (no drug) group indicated that they
were not signiﬁcantly different (Wilcoxon tests, P > 0.05).
Effect of mustard oil on cardiovascular parameters
In the group of animals to be given RX 821002, application of the
ﬁrst mustard oil stimulus to the contralateral MG, the snout or the
ipsilateral MT joints caused the mean arterial blood pressure to
increase signiﬁcantly (repeated-measures ANOVA, F10,90 = 9.231,
F10,80 = 24.16 and F10,90 = 7.955, respectively, P < 0.0001 in each
case), such that 5 min after the stimulus was applied, levels had
risen by 4  2, 26  3 and 6  3 mmHg, respectively. These
increases lasted for an average of 19  6, 37  5 and 20  7 min.
The mustard oil stimulus also resulted in signiﬁcant tachycardia
[repeated-measures ANOVA, F10,90 = 17.38 (contralateral MG),
F10,80 = 3.266 (snout) and F10,90 = 5.976 (ipsilateral MT joints),
P < 0.005 for each site] and, 10 min after it was applied to the con-
tralateral MG, the snout or the ipsilateral MT joints, mean heart rate
had increased by 11  2, 9  4 and 4  1 beats/min, respectively.
The durations for which heart rate remained above control levels
were 38  8, 27  9 and 23  7 min. When mustard oil was
applied to the same three sites in the control (no drug) group, statis-
tically similar blood pressure and heart rate changes to the above
were produced in each case (unpaired t-tests, P > 0.1; Table 1). For
both treatment groups, the pressor effect following mustard oil
application to the snout was signiﬁcantly greater than from the other
two sites [one-way ANOVA followed by Tukey post hoc test,
F2,26 = 25.50 (control (no drug) group), F2,24 = 19.15 (RX 821002
treatment group), P < 0.0001 for both, also see Harris & Clarke,
2003], but mustard oil-induced tachycardia was statistically similar
for all three sites [one-way ANOVA, F2,26 = 1.720 (control (no drug)
group), F2,24 = 1.499 (RX 821002 treatment group), P > 0.1 in each
case].
Following intrathecal administration of RX 821002, mustard oil
application to the snout still caused signiﬁcant [repeated-measures
ANOVA, F10,80 = 19.05 (BP), 3.032 (HR), P < 0.005 in both cases]
increases in mean arterial blood pressure (by 14  3 mmHg, 5 min
after application) and heart rate (by 8  5 beats/min, 10 min after
application), which remained above control levels for 34  8 and
20  8 min, respectively. When injected into the contralateral MG,
the second mustard oil stimulus again caused a signiﬁcant pressor
response (repeated-measures ANOVA, F10,90 = 7.018, P < 0.0001)
such that 5 min after it was applied mean blood pressure had risen
by 3  1 mmHg and remained elevated above controls for
14  6 min. This conditioning stimulus also caused the mean heart
rate to increase by 4  3 beats/min, although this rise was not sta-
tistically signiﬁcant (repeated-measures ANOVA, F10,90 = 1.646,
P > 0.1). However, mustard oil applied to the ipsilateral MT joints
no longer caused a signiﬁcant change in mean arterial blood pres-
sure or heart rate [repeated-measures ANOVA, F10,90 = 0.8026 (BP),
0.8542 (HR), P > 0.5 for both; Fig. 6; Table 1]. In contrast to this,
when the second mustard oil stimulus was applied to any of the
three treatment sites in the control (no drug) group, blood pressure
and heart rate signiﬁcantly rose for a second time in all cases
[repeated-measures ANOVA, contralateral MG: F10,80 = 6.062 (BP),
Fig. 5. Effect of repeated mustard oil application to the plantar metatarsophalangeal (MT) joints ( ﬁrst application;  second application) on heel–medial gas-
trocnemius (MG), toes–tibialis anterior (TA) and toes–semitendinosus (ST) reﬂexes in the absence (top panels) or presence (bottom panels) of RX 821002
(100–300 lg, intrathecally) prior to the second injection. Each point on the graphs represents the median of nine (no drug group) or 10 (RX 821002 group)
experiments, and the vertical lines are either 1st or 3rd quartiles. Mustard oil was applied at 0 min. *Indicates a signiﬁcant difference in the effect of mustard
oil at equivalent time points before and after intrathecal RX 821002 (Wilcoxon tests, P < 0.05).
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12.91 (HR); snout: F10,80 = 29.90 (BP), 10.48 (HR); ipsilateral MT
joints: F10,80 = 3.286 (BP), 2.097 (HR), P < 0.05 in all cases].
Discussion
This study has shown that in the pentobarbitone-anaesthetized rab-
bit, prolonged inhibition of hind limb withdrawal reﬂexes following
acute noxious stimulation of off-limb sites is dependent on an intact
a2-adrenoceptor system in the spinal cord. In addition, a2-adreno-
ceptors were found to be involved in both inhibition and facilitation
of reﬂexes to noxious conditioning stimuli applied to the same limb.
Taken together these data support the proposal that supraspinal nora-
drenergic pathways are involved in heterotopic inhibition as well as
homotopic inhibition or excitation of spinal reﬂex excitability.
Inhibition of hind limb reflexes by heterotopic noxious stimuli
In line with previous ﬁndings (Harris & Clarke, 2003), mustard oil
stimulation of off-limb sites caused inhibition of hind limb reﬂexes.
Both ﬂexors and extensors were inhibited even though reﬂexes to
certain other muscles, for example plantar ﬂexors of the digits, can
be facilitated by such conditioning stimuli (Kalliom€aki et al., 1992;
Morgan et al., 1994; Morgan, 1999). This therefore has features in
common with counter-stimulation phenomena, such as DNIC (Le
Bars et al., 1979a,b; Villanueva & Le Bars, 1995), which has been
demonstrated on reﬂexes following noxious mechanical, thermal and
electrical stimuli in rodents (Schouenborg & Dickenson, 1985;
Kalliom€aki et al., 1992; Falinower et al., 1994) and humans (Willer
et al., 1984, 1989; Terkelsen et al., 2001; Ge et al., 2007), the
effects lasting a number of minutes. In contrast, mustard oil, which
selectively activates C-ﬁbre afferents (Woolf & Wall, 1986) via a
speciﬁc agonistic effect at ankyrin-type transient receptor potential
(TRPA1) channels (Jordt et al., 2004), produced prolonged inhibi-
tion for up to at least 1 h (Harris & Clarke, 2003). As spatial extent
and intensity of the conditioning stimulus are important factors
inﬂuencing amplitude and duration of DNIC (Willer et al., 1984,
1989; Falinower et al., 1994), the area subjected to mustard oil was
restricted to a few mm2 and, although not removed, evidence sug-
gests it causes a nociceptive afferent barrage of only a few minutes
duration (Cook et al., 1987; Harris & Clarke, 2003). Other chemical
conditioning stimuli, for example capsaicin (Gjerstad et al., 2000),
ethylchloride (Parsons & Goetzl, 1945) and formalin (Wen et al.,
2010), similarly produce heterotopic inhibition of long duration,
likely reﬂecting central changes. The beneﬁt of widespread long-
lasting inhibition of normally protective reﬂex responses is unclear,
but it may generate time for a co-ordinated escape response when
the animal has been injured and is under threat (Harris, 1996;
LeDoux, 1996).
Table 1. Changes in arterial blood pressure and heart rate following mus-
tard oil application to the contralateral MG, snout or ipsilateral MT joints
Site of application
No drug (control) group RX 821002 treatment group
Pre-mustard Post-mustard Pre-mustard Post-mustard
Contralateral MG
1st application
BP (mmHg) 84  7 93  6* 94  4 97  3*
HR (bpm) 269  9 288  9* 297  9 308  7*
2nd application
BP (mmHg) 80  4 87  5* 86  4 89  5*
HR (bpm) 286  8 294  7* 305  9 309  8
Snout
1st application
BP (mmHg) 80  5 109  6* 87  3 113  3*
HR (bpm) 273  7 285  5* 299  12 308  9*
2nd application
BP (mmHg) 74  6 94  6* 85  6 99  7*
HR (bpm) 279  10 287  10* 304  9 312  7*
MT joints
1st application
BP (mmHg) 81  5 86  6* 91  3 97  3*
HR (bpm) 280  8 287  8* 300  8 304  8*
2nd application
BP (mmHg) 78  5 81  6* 82  5 84  6
HR (bpm) 285  10 287  11* 305  8 305  8
In the control (no drug) treatment group (n = 9), both mustard oil applica-
tions were in the absence of RX 821002, whilst the second mustard oil
conditioning stimulus was performed after administration of RX 821002
(100–300 lg, intrathecally) in the RX 821002 treatment group (n = 10).
Blood pressure and heart rate values are means  SEM, and were taken
5 min and 10 min after mustard oil application, respectively.
BP, arterial blood pressure; HR, heart rate; MG, medial gastrocnemius; MT,
metatarsophalangeal.
*A signiﬁcant difference from the pre-mustard oil state (repeated-measures
ANOVA, see main text for statistical details). Fig. 6. Effect of mustard oil applied to the metatarsophalangeal (MT) joints
on mean arterial blood pressure (top panel) and heart rate (bottom panel)
before () and after () administration of RX 821002 (100–300 lg, intrathe-
cally). Each point on the graph represents the mean of 10 experiments, and
error bars are SEM. Mustard oil was applied at 0 min, and RX 821002 was
administered 20–30 min before the second mustard oil stimulus was applied.
Mustard oil caused a signiﬁcant increase in blood pressure and heart rate
before but not after administration of RX 821002.
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Involvement of noradrenergic mechanisms in heterotopic
inhibition
Blockade of spinal a2-adrenoceptors by intrathecal RX 821002 pre-
vented mustard oil-induced heterotopic inhibition of reﬂexes. This
result is supported by the previous ﬁnding that intravenous idazoxan
attenuated inhibition of sural-MG reﬂexes following electrical stimu-
lation of high-threshold afferents in either forelimb or the contralat-
eral hind limb (Taylor et al., 1991). Possible peripheral effects of
intrathecal RX 821002 (i.e. due to leakage into the circulation) are
likely to be minimal, as it induces changes in reﬂexes and blood
pressure in intact but not spinalized animals (Harris & Clarke, 1993;
Ogilvie & Clarke, 1998), conﬁrming a spinal site of action. Further-
more, systemic dexmedetomidine, an a2-agonist, caused a reduction
in DNIC/CPM inhibition (Sanada et al., 2009; Baba et al., 2012)
via a proposed supraspinal site of action; an effect of RX 821002
supraspinally would therefore be predicted to enhance DNIC, which
clearly was not the case in the present studies. Because mustard oil-
induced heterotopic inhibition of reﬂexes also cannot be generated
in spinalized animals (Harris & Clarke, 2003), its effects are pre-
sumably due to noradrenaline released from descending supraspinal
pathways which, by the simplest interpretation, acts at pre-synaptic
a2-adrenoceptors on heel or toe primary afferents to reduce excita-
tory neurotransmitter release (Kuraishi et al., 1985; Takano et al.,
1993; Ueda et al., 1995; Pan et al., 2002; Kawasaki et al., 2003) or
postsynaptically to inhibit interneurons in the reﬂex arcs (North &
Yoshimura, 1984; Sonohata et al., 2004; Lu & Perl, 2007; Gassner
et al., 2009). Anatomical studies in many species, including the rab-
bit (Blessing et al., 1978, 1981, 1986), show descending ﬁbres orig-
inate from the A5, A6 (nucleus locus coeruleus, LC and
subcoeruleus, SC) and A7 noradrenergic nuclei in the brainstem
(Dahlstr€om & Fuxe, 1964), direct stimulation of which inhibits
spinal neurons via a2-adrenoceptors (Jones, 1991; Millan, 2002; Per-
tovaara, 2006). However, lesions incorporating these nuclei do not
reduce DNIC, which instead appears to arise from subnucleus reticu-
laris dorsalis in the caudal medulla (Bouhassira et al., 1990, 1992a,
b, 1993, 1995). Some involvement of A5–A7 should not be entirely
discounted though, as during acute hind paw inﬂammation, hetero-
topic inhibition involved LC/SC (Tsuruoka et al., 2004). Until now,
investigation of spinal noradrenergic pathways in heterotopic inhibi-
tion of ﬂexor vs. extensor reﬂexes has been minimal, but some evi-
dence suggests noradrenergic mechanisms are involved in
heterotopic inhibition of dorsal horn neurons (Gjerstad et al., 2000)
and tail ﬂick responses (Wen et al., 2010). However, similar to ear-
lier studies (Taylor et al., 1991), these groups also reported the
additional involvement of opioidergic pathways. The inhibitory path-
ways recruited may differ according to the conditioning stimulus
(Wen et al., 2010) or the site from which DNIC is evoked (Taylor
et al., 1991). Complete reversal of mustard oil-induced effects by
RX 821002 in the current studies suggests a dominance of noradren-
ergic inﬂuences in this anaesthetized preparation (see below). Fur-
ther studies are required to identify the source of noradrenergic
pathways involved.
Involvement of noradrenergic mechanisms in homotopic
conditioning stimuli
In contrast to broad inhibition of cutaneomuscular reﬂexes from off-
limb sites, consequences of conditioning stimulation of the same limb
are more complex, being inhibitory or facilitatory depending on the
area stimulated and reﬂex studied, as well as being inﬂuenced by
descending pathways (Clarke & Harris, 2004). Hence, mustard oil to
the MT joints caused signiﬁcant inhibition of heel–MG reﬂexes but
long-lasting facilitation of toes–ﬂexor responses (Clarke et al.,
2001b; Harris & Clarke, 2003; Harris et al., 2004). These changes
mirror modular organization of reﬂexes per se (Clarke et al., 1989;
Schouenborg & Kalliomaki, 1990; Weng & Schouenborg, 1996;
Andersen et al., 1999; Levinsson et al., 1999), and increase excitabil-
ity of reﬂexes that protect the injured site whilst reducing those that
aggravate the injury. The present studies have now found that both
inhibition and facilitation can be completely abolished by intrathecal
RX 821002, indicating involvement of noradrenergic pathways in dif-
ferential homotopic inhibition or sensitization of certain spinal
reﬂexes, hence in controlling appropriate reﬂex responses to injury at
a particular site. As it is well established that a2-adrenoceptors
directly mediate pre- and postsynaptic inhibition not facilitation (Per-
tovaara, 2006), the mechanisms underlying this dual effect of RX
821002 are likely to be complex, with mustard oil-induced facilitation
involving a noradrenergic ‘enabling switch’, i.e. a disinhibitory pro-
cess, allowing excitatory (sensitizing) pathways such as those involv-
ing glutamate and substance P to be expressed (Harris et al., 2004).
Electrophysiological studies have shown a2-adrenoceptors can medi-
ate hyperpolarization (North & Yoshimura, 1984; Sonohata et al.,
2004; Lu & Perl, 2007; Gassner et al., 2009) of putative c-aminobu-
tyric acid (GABA)-ergic inhibitory and glutamatergic excitatory
interneurons, presenting a means by which bulbospinal noradrenergic
pathways could suppress inhibition and facilitation of spinal transmis-
sion (and reﬂexes), respectively (Lu & Perl, 2007). Mustard oil-
induced up- or downregulation of activity in noradrenergic pathways
could therefore strengthen or weaken these spinal effects, and evi-
dence for such changes, from the LC/SC in particular (Tsuruoka &
Willis, 1996; Tsuruoka et al., 2004; Viisanen & Pertovaara, 2007;
Maeda et al., 2009), is seen in acute inﬂammation (Green et al.,
1998; Omote et al., 1998; Mansikka et al., 2004) and nerve injury
(Xu et al., 1999; Wei & Pertovaara, 2006; Rahman et al., 2008; De
Felice et al., 2011; Hughes et al., 2013).
Tonic effects and anaesthetic considerations
Tonic inhibition of spinal excitability may be mediated by suprasp-
inal sites different to those involved in DNIC (Bouhassira et al.,
1995). Certainly, spinal reﬂexes are subject to powerful tonic
descending noradrenergic inhibition that can be alleviated by
intrathecal a2-adrenoceptor antagonists (including RX 821002), but
not the a1-antagonist prazosin, in decerebrated (Harris & Clarke,
1992, 1993; Clarke et al., 1998, 2000, 2001a) or alphaxalone/
alphadolone (Saffan)-anaesthetized rabbits (Ogilvie et al., 1999).
However, in the present studies, when given by the same route and
at similar doses, RX 821002 had no effect per se on any reﬂex. In
addition, although RX 821002 caused a signiﬁcant decrease in mean
arterial blood pressure along with a signiﬁcant increase in heart rate
(likely a baroreceptor-mediated compensatory response), previously
pressor effects have been observed in decerebrated animals (Harris
& Clarke, 1993; Clarke et al., 1998, 2000), presumably due to block
of tonic descending noradrenergic inhibition of sympathetic pregan-
glionic neurons (Coote & Lewis, 1995). In contrast, intrathecal RX
821002 had no effect on blood pressure in Saffan-anaesthetized ani-
mals (Ogilvie et al., 1999). Taken together, these data indicate that
mixed effects of a2-adrenoceptor blockade on control of sympathetic
and somatic motor outﬂows are observed depending on the presence
and type of anaesthesia; in particular, that tonic noradrenergic
descending inhibition is suppressed in pentobarbitone-anaesthetized
animals. Although DNIC is dependent on choice (Alarcon & Cer-
vero, 1989) and depth (Tomlinson et al., 1983; Jinks et al., 2003)
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of anaesthesia, in the present experiments it is clear from the control
(no drug) group that the anaesthetic regime was highly stable
throughout and did not affect repeatability of heterotopic or homo-
topic conditioning stimuli. Therefore, whilst noradrenergic pathways
may be particularly prominent in heterotopic inhibition in pentobar-
bitone-anaesthetized rabbits, it does not diminish the fact these path-
ways can potentially be activated by noxious stimuli in awake
behaving animals. This supports the previous observation that
descending control of reﬂex excitability is a dynamic process (Harris
& Clarke, 2003), and that anaesthetic contribution to the balance of
supraspinal controls always needs to be considered.
Cardiovascular responses to mustard oil
Mustard oil application to any site caused signiﬁcant increases in
mean arterial blood pressure and heart rate (likely due to activation
of brain stem defence areas, for example the dorsolateral periaque-
ductal grey matter; Blessing, 1997), with the snout stimulus being
particularly effective. However, reﬂex modulation was clearly not
driven by these changes, as the greater cardiovascular effects of the
snout stimulus were not reﬂected in a greater level of heterotopic
inhibition of reﬂexes, and mustard oil to the MT joints clearly had a
differential effect on reﬂexes. In addition, this latter site was the
only one where mustard oil-induced cardiovascular responses were
blocked by intrathecal RX 821002 even though antagonism of
a2-adrenoceptors prevented its modulation of all reﬂex responses.
This provides further evidence for differential activation of brain
circuits by noxious stimuli applied to different parts of the body.
Possible 5-HT involvement in observed effects
RX 821002 is the 2-methoxy derivative of idazoxan, which has no
appreciable afﬁnity for non-adrenergic imidazoline receptors and high
selectivity for a2- vs. a1-adrenoceptors (Hudson et al., 1992;
O’Rourke et al., 1994; Clarke & Harris, 2002). It is therefore possi-
ble to be conﬁdent that most, if not all, of the effects observed were
via noradrenaline acting at a2-adrenoceptors. However, it is possible
some of the effect of RX 821002 could be due to its weak antagonis-
tic actions at 5-HT1A receptors (Newman-Tancredi et al., 1998; Ogil-
vie & Clarke, 1998; Clarke & Harris, 2002). Descending 5-HT-ergic
pathways exist in the rabbit (Felten & Cummings, 1979; Howe et al.,
1983; Yamada & Sano, 1985), and tonic inhibition of reﬂexes via 5-
HT1A receptors has been shown (Clarke et al., 1996; Ogilvie et al.,
1999). Studies in the rat suggest involvement of descending 5-HT-
ergic pathways in DNIC (Dickenson et al., 1981; Chitour et al.,
1982; Kraus et al., 1982) and modulation of spinal cord excitability
(Millan, 2002). Future studies using intrathecal administration of
selective 5-HT receptor antagonists (e.g. WAY-100635) could there-
fore investigate whether 5-HT1A, or other 5-HT receptor subtypes,
are involved in heterotopic and homotopic modulation in this model.
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